Document is current
Any future updates will be listed below
-
Authors
Qiu, Yun
Hüther, Juliana A.
Wank, Bianca
Rath, Antonia
Tykwe, René
Aldrovandi, Maceler
Henkelmann, Bernhard
Mergner, Julia https://orcid.org/0000-0002-4332-1280
Nakamura, Toshitaka
Laschat, Sabine
Conrad, Marcus https://orcid.org/0000-0003-1140-5612
Stöhr, Daniela https://orcid.org/0009-0004-6731-8707
Rehm, Markus https://orcid.org/0000-0001-6149-9261
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (390740016, MO 3226/4-1, 471011418, 471011418, INST 95/1650-1 FUGG, TRR353/1 – 471011418)
- License Information
-
More Information
Article History
Received: 9 October 2024
Revised: 28 March 2025
Accepted: 7 April 2025
First Online: 29 April 2025
Competing interests
: MC is a co-founder and shareholder of ROSCUE Therapeutics GmbH and holds patents on compounds modulating ferroptosis.
: All work was conducted in commercially available cell lines. Ethics approval was not required for this work.
